Download - Evonik Industries

+++ Evonik Industries to expand its Asian special polymer capacities
evonik industries that is already one of the leading global providers
of methacrylate chemical products now plans to expand its production
capacities for PMMA molding compounds at its facilities south
of Shanghai (china), and in taichung (taiwan). Fur ther more,
evonik has expanded its methacrylic acid capacities in the Shanghai
MAtcH supercomplex, which began operating just nine months
ago. „we want to grow in particular in places where markets develop
at above­average rates. our polymer business in Asia is showing
remarkable growth rates. that’s why we decided to invest
quickly and consistently in the expansion of our plants,“ explained
Dr. klaus engel, chairman of evonik industries’ ex ec utive Board.
the taichung plant began running in 2007 as part of the joint
venture evonik Forhouse optical Polymers corporation. it produces
some 40,000 metric tons of PleXiGlAS® molding compounds
a year for light guide panels used in flat­screen monitors,
Produced in Shanghai,
PLEXIGLAS® molding
compounds are supplied
to the automotive industry
in Asia, among others.
PLEXIGLAS® CoolTouch®
specialty compounds,
for example, with their
heat-reflective effect,
are suitable for roof
applications
+++ New production plant for active pharmaceutical ingredients in China
evonik industries has started up a production plant for active
pharmaceutical ingredients in china. it will supply the chinese
market, among others, and has a capacity of 70 cubic meters that
can be doubled if required. the plant, in the city of nanning in
Guangxi province, has been set up in collaboration with a european
pharmaceutical company for which evonik will produce various
active ingredients under a multi­year supply contract and in
compliance with cGMP (current Good Manufacturing Practices),
the pharmaceutical industry‘s chief quality assurance guidelines.
the plant was erected in just 15 months. „that would not have
been possible without the excellent support of the administration
of the autonomous province of Guangxi, the city of nanning, and
wuming district,“ said Dr. Hans­Josef ritzert, head of evonik‘s
ex clusive Synthesis & Amino Acids Business line, at the official
opening ceremony, attended by customers from all over the world
elements32 evonik science newsletter
news
and demand for these flat­screen monitors has risen significantly,
particularly in Asia. the expanded taichung plant, with capacities
to produce another 20,000 metric tons a year, is scheduled to become
operational in the second quarter of 2011.
Since november 2008, in its first expansion stage, the Shanghai
PMMA plant had been producing some 18,000 metric tons a
year. the products are supplied as a comprehensive line of
PleXiGlAS® molding compounds to various industries in Asia, including
the automotive, lighting, and electronics industries. the
de mand for PleXiGlAS® molding compounds also has increased
considerably in these market segments, prompting the company
to accelerate the construction of a second expansion stage with
capacities of another 18,000 metric tons a year. the expanded
pro duction capacities will become operational in the second half
of 2011.
Beyond that, evonik has expanded its
production capacity of methacrylic acid at
the MAtcH supercomplex in Shang hai to
25,000 metric tons. Pro duc tion at the expanded
capacity has begun this May.
these steps are the continuation of a
series of Asian investments for evonik indu
stries: nine months ago, in november
2009, the Group finished building the
MAtcH supercomplex for producing polymers,
polymer precursors, and coating systems
in Shanghai and began operating the
€ 250 million plant. the plant is the Group’s
largest investment in china.
as well as chinese political figures. evonik has been active in nanning
since 2001, initially as a partner in a joint venture and since
2005 as the sole owner of this company. now operating as evonik
rexim (nanning) Pharmaceuticals co. ltd., the company produces
cGMP­compliant amino acids and amino acid derivatives by
biotechnological processes. with the new active­ingredient production
plant evonik now has another strong foothold in nanning.
„the new plant is an expression of our horizontal integration
strategy,“ said ritzert. the term „horizontal integration“ stands
for a network of western (europe, nAFtA) and Asian production
sites from which evonik offers customers tailored and exclusive
solutions along the entire value chain of active pharmaceutical
ingredients. „with this plant we will further consolidate our position
as a high performing partner for exclusive synthesis,“ added
ritzert.
3